Bone Metastasis and Osteoporosis - Therapy / Bone Imaging
Posted on: 11/01/2009
ALPHARADIN Clinical Update (Nov-Dec 2012)
DENOSUMAB: An effective agent to prevent progression of bone metastases (March-April 2012)
"ALPHARADIN" (Radium-223 Chloride): A New Treatment for Bone Metastases (March-April 2012)
Imagine for Bone Metastases (March-April 2011)
Denosumab: Establishing a Role as a Remedy for Suboptimal Bisphosphonate Therapy (Nov-Dec 2009)
Of Bones and Drugs: New Trial Results Regarding Zometa and Denosumab (May-June 2009)
DENOSUMAB - Amgen's Forthcoming Drug, An Inhibitor of Bone Resorption (September 2008)
Skeletal Scintigraphy With 18F Sodium Fluoride Positron Emission Tomography (18F-fluoride PET) Offers Greater Overall Accuracy Than 99mTechnetium-MDP for Prostate Cancer Patients (May 2008)
"Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients with High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies" (JCO August 1, 2007) (January 2008)
Osteonecrosis of the Jaw, Androgen Deprivation, and Bisphosphonates (May 2007)
Zometa: Once Yearly Dosage Found Effective In Combating Osteoporosis In Men On ADT Without Bone Metastases (November 2006)
Modified PSA Guidelines For Bone Scanning (October 2006)
Painful Bone Metastases: RTOG Trial 9701 Finds Response Rate From 8Gy Single Fraction Radiotherapy As Effective As A Longer Course (July 2005)
The Utility of Bone Scans in Recurrent Prostate Cancer (June 2005)
Bone Metastases In Prostate Cancer And Therapy With Zometa. (February 2005)
The use of “Zometa” and “Pamidronate” in prevention of osteoporosis and in retarding the progression of metastases in bone. (November 2002)
In This Section
